Literature DB >> 15578993

Towards multifunctional synthetic vectors.

Barbara Demeneix1, Zahra Hassani, Jean-Paul Behr.   

Abstract

Recent progress on the fronts of design, formulation and delivery with synthetic vectors has increased the potential of non-viral approaches to attain therapeutic applications. However, a number of hurdles remain to be cleared. On the one hand, we have the problem of producing and formulating stable, diffusible complexes and on the other hand, we have to face the fact that in vivo delivery is probably too complex and multifaceted to be achieved successfully with a single carrier molecule in most instances. This review concentrates on this latter aspect and the design of artificial multi-component vectors aimed at providing solutions to membrane crossing, endosomal escape and navigation through the nuclear pore. In many instances the solutions proposed have been inspired by natural mechanisms exploited by bacteria and viruses. However, entirely novel chemical approaches such as monomolecular DNA condensation via detergent dimerization, or endosome disruption by osmotic swelling, are also being investigated and developed. The combination of these naturally inspired and chemically-originated approaches is bringing us continually closer to the concept of constructing an artificial virus capable of delivering viable nucleic acid-based pharmaceuticals to defined cells in vivo. This review considers the most successful current solutions to the main biological barriers to gene delivery including appropriate DNA compaction, cell targeting and entry, vacuole escape, nuclear import and in vivo delivery. In the latter section, emphasis is placed on one of the most versatile non-viral vectors currently available, linear polyethylenimine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15578993     DOI: 10.2174/1566523043345940

Source DB:  PubMed          Journal:  Curr Gene Ther        ISSN: 1566-5232            Impact factor:   4.391


  7 in total

Review 1.  The potential application of gene therapy in the treatment of traumatic brain injury.

Authors:  Fang Shen; Liang Wen; Xiaofeng Yang; Weiguo Liu
Journal:  Neurosurg Rev       Date:  2007-08-09       Impact factor: 3.042

Review 2.  Nanocarriers' entry into the cell: relevance to drug delivery.

Authors:  Hervé Hillaireau; Patrick Couvreur
Journal:  Cell Mol Life Sci       Date:  2009-06-05       Impact factor: 9.261

3.  A combinatorial library of bi-functional polymeric vectors for siRNA delivery in vitro.

Authors:  Jeisa M Pelet; David Putnam
Journal:  Pharm Res       Date:  2012-09-28       Impact factor: 4.200

4.  TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors.

Authors:  Vijay A Sethuraman; You Han Bae
Journal:  J Control Release       Date:  2006-12-13       Impact factor: 9.776

5.  Renal medullary 11 beta-hydroxysteroid dehydrogenase type 1 in Dahl salt-sensitive hypertension.

Authors:  Yong Liu; Ravinder J Singh; Kristie Usa; Brian C Netzel; Mingyu Liang
Journal:  Physiol Genomics       Date:  2008-09-30       Impact factor: 3.107

6.  Peptide-matrix-mediated gene transfer of an oxygen-insensitive hypoxia-inducible factor-1alpha variant for local induction of angiogenesis.

Authors:  Diana Trentin; Heike Hall; Sandra Wechsler; Jeffrey A Hubbell
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

7.  Peptide dendrimer/lipid hybrid systems are efficient DNA transfection reagents: structure--activity relationships highlight the role of charge distribution across dendrimer generations.

Authors:  Albert Kwok; Gabriela A Eggimann; Jean-Louis Reymond; Tamis Darbre; Florian Hollfelder
Journal:  ACS Nano       Date:  2013-05-17       Impact factor: 15.881

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.